Literature DB >> 10837672

Extravasation of macromolecules.

.   

Abstract

Macromolecules can extravasate across the normal endothelium by transcapillary pinocytosis as well as by passage through interendothelial cell junctions, gaps or fenestrae. The main biological factors that control extravasation of a solute include regional differences in the capillary structures, the disease state of the organ or tissue, and the rate of blood and lymph supply. Physicochemical properties that are of profound significance in the extravasation of macromolecules are molecular size, shape, charge and hydrophilic/lipophilic balance (HLB) characteristics. Extravasation of small drugs, proteins, oligonucleotides and genes can be controlled by conjugating or forming complexes with macromolecular carriers. This requires a thorough understanding of the relationship between the chemical structures, physicochemical properties and the pharmacokinetics of both carrier and active molecules. This review article discusses the extravasation of macromolecules from the view points of pharmacokinetics and drug delivery systems, with the main emphasis on the extravasation across the liver, kidney and tumor capillaries.

Entities:  

Year:  1998        PMID: 10837672     DOI: 10.1016/s0169-409x(98)00006-4

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  15 in total

1.  BioDMET: a physiologically based pharmacokinetic simulation tool for assessing proposed solutions to complex biological problems.

Authors:  John F Graf; Bernhard J Scholz; Maria I Zavodszky
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-12-10       Impact factor: 2.745

2.  Plasmid delivery in vivo from porous tissue-engineering scaffolds: transgene expression and cellular transfection.

Authors:  Jae-Hyung Jang; Christopher B Rives; Lonnie D Shea
Journal:  Mol Ther       Date:  2005-09       Impact factor: 11.454

3.  Tissue-specific characteristics of in vivo electric gene: transfer by tissue and intravenous injection of plasmid DNA.

Authors:  Oranuch Thanaketpaisarn; Makiya Nishikawa; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Pharm Res       Date:  2005-06-08       Impact factor: 4.200

4.  In vivo miRNA delivery in whitefish: Synthetic MiR92b-3p uptake and the efficacy of gene expression silencing.

Authors:  Paweł Brzuzan; Maciej Woźny; Bogdan Lewczuk; Maciej Florczyk; Piotr Gomułka; Paulina Budzińska; Michał Wesołowski; Stefan Dobosz
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-21

5.  Predicting monoclonal antibody pharmacokinetics following subcutaneous administration via whole-body physiologically-based modeling.

Authors:  Shihao Hu; David Z D'Argenio
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-06-04       Impact factor: 2.745

6.  PEG-Peptide Inhibition of Scavenger Receptor Uptake of Nanoparticles by the Liver.

Authors:  Rondine J Allen; Basil Mathew; Kevin G Rice
Journal:  Mol Pharm       Date:  2018-08-13       Impact factor: 4.939

7.  Biocompatible blood pool MRI contrast agents based on hyaluronan.

Authors:  Wenlian Zhu; Dmitri Artemov
Journal:  Contrast Media Mol Imaging       Date:  2010-10-28       Impact factor: 3.161

8.  An Activatable NIR Fluorescent Rosol for Selectively Imaging Nitroreductase Activity.

Authors:  Jessica L Klockow; Kenneth S Hettie; Edward L LaGory; Eui Jung Moon; Amato J Giaccia; Edward E Graves; Frederick T Chin
Journal:  Sens Actuators B Chem       Date:  2019-11-30       Impact factor: 7.460

Review 9.  A critical review of lipid-based nanoparticles for taxane delivery.

Authors:  Lan Feng; Russell J Mumper
Journal:  Cancer Lett       Date:  2012-07-13       Impact factor: 8.679

Review 10.  Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.

Authors:  Nicolas Bertrand; Jun Wu; Xiaoyang Xu; Nazila Kamaly; Omid C Farokhzad
Journal:  Adv Drug Deliv Rev       Date:  2013-11-22       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.